Pacific Biosciences of California, Inc. Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)
Pacific Biosciences of California, Inc. (PACB) reported Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) of $40.00 million for the 3-month period ending 2024-12-31, per its 10-Q filed 2025-11-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill · last filed 2025-11-06
- Pacific Biosciences of California, Inc. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2024-12-31 was $40.00M.
| Period end | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 3 month |
|---|---|
| 2024-12-31 | $40.00M 10-Q · filed 2025-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |